Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Proteins that interact with calgranulin B in the human colon cancer cell line HCT-116.

Myung JK, Yeo SG, Kim KH, Baek KS, Shin D, Kim JH, Cho JY, Yoo BC.

Oncotarget. 2017 Jan 24;8(4):6819-6832. doi: 10.18632/oncotarget.14301.

2.

Bisphenol A and its analogues disrupt centrosome cycle and microtubule dynamics in prostate cancer.

Ho SM, Rao R, To S, Schoch E, Tarapore P.

Endocr Relat Cancer. 2017 Feb;24(2):83-96. doi: 10.1530/ERC-16-0175. Epub 2016 Dec 20.

PMID:
27998958
3.

Microtubule-organizing centers: from the centrosome to non-centrosomal sites.

Sanchez AD, Feldman JL.

Curr Opin Cell Biol. 2017 Feb;44:93-101. doi: 10.1016/j.ceb.2016.09.003. Epub 2016 Sep 22. Review.

PMID:
27666167
4.

Reversine Induced Multinucleated Cells, Cell Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer Cells.

Lu YC, Lee YR, Liao JD, Lin CY, Chen YY, Chen PT, Tseng YS.

PLoS One. 2016 Jul 6;11(7):e0158587. doi: 10.1371/journal.pone.0158587. eCollection 2016.

5.

KIFC1: a promising chemotherapy target for cancer treatment?

Xiao YX, Yang WX.

Oncotarget. 2016 Jul 26;7(30):48656-48670. doi: 10.18632/oncotarget.8799. Review.

6.

Antitumor effects of calgranulin B internalized in human colon cancer cells.

Kim K, Kim KH, Roh K, Yoo BC, Ku JL, Shin YK, Cho JY, Kim M, Kwon MH, Goh SH, Chang HJ, Oh JH.

Oncotarget. 2016 Apr 12;7(15):20368-80. doi: 10.18632/oncotarget.7783.

7.

Over-expression of Plk4 induces centrosome amplification, loss of primary cilia and associated tissue hyperplasia in the mouse.

Coelho PA, Bury L, Shahbazi MN, Liakath-Ali K, Tate PH, Wormald S, Hindley CJ, Huch M, Archer J, Skarnes WC, Zernicka-Goetz M, Glover DM.

Open Biol. 2015 Dec;5(12):150209. doi: 10.1098/rsob.150209.

8.

Prognostic Significance and Functional Role of CEP57 in Prostate Cancer.

Mang J, Korzeniewski N, Dietrich D, Sailer V, Tolstov Y, Searcy S, von Hardenberg J, Perner S, Kristiansen G, Marx A, Roth W, Herpel E, Grüllich C, Popeneciu V, Pahernik S, Hadaschik B, Hohenfellner M, Duensing S.

Transl Oncol. 2015 Dec;8(6):487-96. doi: 10.1016/j.tranon.2015.11.004.

9.

Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer.

Zeng YR, Han ZD, Wang C, Cai C, Huang YQ, Luo HW, Liu ZZ, Zhuo YJ, Dai QS, Zhao HB, Liang YX, Zhong WD.

BMC Urol. 2015 Aug 29;15:90. doi: 10.1186/s12894-015-0085-7.

10.

KIFC1 is a novel potential therapeutic target for breast cancer.

Li Y, Lu W, Chen D, Boohaker RJ, Zhai L, Padmalayam I, Wennerberg K, Xu B, Zhang W.

Cancer Biol Ther. 2015;16(9):1316-22. doi: 10.1080/15384047.2015.1070980. Epub 2015 Jul 15.

11.

The Aspergillus nidulans bimC4 mutation provides an excellent tool for identification of kinesin-14 inhibitors.

Wang B, Li K, Jin M, Qiu R, Liu B, Oakley BR, Xiang X.

Fungal Genet Biol. 2015 Sep;82:51-5. doi: 10.1016/j.fgb.2015.06.005. Epub 2015 Jun 24.

12.

Polo-like kinases (plks), a key regulator of cell cycle and new potential target for cancer therapy.

Lee SY, Jang C, Lee KA.

Dev Reprod. 2014 Mar;18(1):65-71. doi: 10.12717/DR.2014.18.1.065.

13.

Effects of the ninein-like protein centrosomal protein on breast cancer cell invasion and migration.

Liu Q, Wang X, Lv M, Mu D, Wang L, Zuo W, Yu Z.

Mol Med Rep. 2015 Aug;12(2):1659-64. doi: 10.3892/mmr.2015.3650. Epub 2015 Apr 20.

14.

Centrobin-mediated regulation of the centrosomal protein 4.1-associated protein (CPAP) level limits centriole length during elongation stage.

Gudi R, Haycraft CJ, Bell PD, Li Z, Vasu C.

J Biol Chem. 2015 Mar 13;290(11):6890-902. doi: 10.1074/jbc.M114.603423. Epub 2015 Jan 23.

15.

Occurrence of secondary malignancies in chronic myeloid leukemia during therapy with imatinib mesylate-single institution experience.

Helbig G, Bober G, Seweryn M, Wichary R, Tukiendorf A, Sedlak L, Oleksy T, Kyrcz-Krzemień S.

Mediterr J Hematol Infect Dis. 2015 Jan 1;7(1):e2015003. doi: 10.4084/MJHID.2015.003. eCollection 2015.

16.

Cytoskeleton targeting value in prostate cancer treatment.

Martin SK, Kamelgarn M, Kyprianou N.

Am J Clin Exp Urol. 2014 Apr 5;2(1):15-26. eCollection 2014. Review.

17.

Causes and consequences of centrosome abnormalities in cancer.

Godinho SA, Pellman D.

Philos Trans R Soc Lond B Biol Sci. 2014 Sep 5;369(1650). pii: 20130467. doi: 10.1098/rstb.2013.0467. Review.

18.

Centrobin-centrosomal protein 4.1-associated protein (CPAP) interaction promotes CPAP localization to the centrioles during centriole duplication.

Gudi R, Zou C, Dhar J, Gao Q, Vasu C.

J Biol Chem. 2014 May 30;289(22):15166-78. doi: 10.1074/jbc.M113.531152. Epub 2014 Apr 3.

19.

Link between DNA damage and centriole disengagement/reduplication in untransformed human cells.

Douthwright S, Sluder G.

J Cell Physiol. 2014 Oct;229(10):1427-36. doi: 10.1002/jcp.24579.

20.

Centrosome dysfunction contributes to chromosome instability, chromoanagenesis, and genome reprograming in cancer.

Pihan GA.

Front Oncol. 2013 Nov 12;3:277. doi: 10.3389/fonc.2013.00277. eCollection 2013. Review.

Supplemental Content

Support Center